MoonLake Immunotherapeutics MLTX
11.03 USD +0.24 (+2.22%)
Regular-session close
10.91 -0.12 -1.09%
Pre-market · Nov 20, 8:28 AM ET
10.85 Day range 11.69
9.46 52-week range 23.29
- YTD
- -16.31%
- 1 year
- -18.54%
News
benzinga.com MoonLake Q3 EPS $(0.93) Misses $(0.78) Estimate MoonLake (NASDAQ:MLTX) reported quarterly losses of $(0.93) per share which missed the analyst consensus estimate of $(0.78) by 19.23 percent. This is a 15.45 percent increase over losses of $(1.10)…
benzinga.com What's Going On with MoonLake Immunotherapeutics Stock on Thursday? MoonLake stock rallies after AbbVie HS data misses competitor benchmarks, reinforcing sonelokimab's competitive positioning ahead of 2027 launch plans.
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Profusa (NASDAQ:PFSA) shares moved upwards by 35.4% to $1.15 during Thursday's regular session. Karyopharm Therapeutics (NASDAQ:KPTI) shares increased by 29.12% to $0.55. The company's market…
benzinga.com Healthcare Services Posts Upbeat Q3 Earnings, Joins Pool, Spotify And Other Big Stocks Moving Higher On Thursday U.S. stocks fell, but Healthcare Services Group jumped 8.2% on an earnings beat. Biohaven led gainers, surging 30.5% after FDA news.
